Navigation Links
Thoratec Reports Third Quarter Fiscal 2011 Results
Date:11/1/2011

tinuing operations on a GAAP basis

$
8,989$
5,480$
57,230$
46,381Share-based compensation expense:- Cost of product sales

3783221,081947- Selling, general and administrative

2,5391,8587,5786,074- Research and development

1,0117913,0732,602Amortization of purchased intangibles

2,6092,4467,1087,326Impact of ASC 470-20

-2,1293,1276,168Levitronix Medical transaction costs

1,462-2,859-Levitronix fair market value inventory adjustments

1,3861,386-Income tax effect of non-GAAP income before tax

(239)607(347)434Income tax effect of non-GAAP adjustments

(3,025)(2,820)(8,760)(8,236)Net income from continuing operations on a non-GAAP basis

$
25,110$
20,813$
74,335$
,696 Three Months Ended Nine Months Ended Diluted net income from continuing operations per share reconciliation

October 1, 2011October 2, 2010October 1, 2011October 2, 2010Diluted net income from continuing operations per share on a GAAP basis

$
.31$
.26$
.95$
.78Share-based compensation expense:- Cost of product sales

0.010.000.020.02- Selling, general and administrative

0.040.020.120.09- Research and development

0.020.010.050.04Amortization of purchased intangibles

0.040.040.110.11Levitronix Medical transaction costs

0.02-0.05-Levitronix fair market value inventory adjustments

0.02-0.02-Income tax effect of non-GAAP income before tax

(0.00)0.01(0.01)0.01Income tax effect of non-GAAP adjustments

(0.05)(0.02)(0.13)(0.09)Convertible debt dilution and two-class method impact--(0.01)Diluted net income from continuing operations per share on a non-GAAP basis

$
.41$
.32$
.18$
.95 Three Months Ended Nine Months Ended October 1, 2011October 2, 2010October 1, 2011October 2, 2010Shares used to compute diluted net income from continuing operations per share reconcil
'/>"/>

SOURCE Thoratec Corporation
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17

Related medicine technology :

1. Thoratec Announces FDA Approval of HeartMate II(R) for Bridge-To-Transplantation
2. Thoratec Says Interim Data Analysis Demonstrates Statistical Superiority for the HeartMate II(R) in Destination Therapy Trial
3. Thoratec Reports 14 Percent Growth in Cardiovascular Division Sales as Third Quarter Revenues Increase Nine Percent
4. Thoratec Reports a 19 Percent Increase in Annual Revenues as Cardiovascular Division Revenues Increase 30 Percent in 2009
5. Thoratec Announces Acquisition of Innovative Catheter-Based Heart Pump Technology
6. Thoratec Schedules Fiscal 2009 Year-End Conference Call, Webcast
7. Thoratec Presentation at Canaccord Adams Conference to be Webcast
8. Thoratec Announces FDA Approval of HeartMate II(R) for Destination Therapy
9. Thoratec Investor Meeting to Review HeartMate II (R) Destination Therapy Trial Data to Be Webcast
10. Thoratec Presentation at Piper Jaffray Conference to be Webcast
11. Thoratec Presentation at Raymond James Conference to Be Webcast
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/16/2013)... and MECHELEN, Belgium , May 17, ... (NYSE: ABBV ) announced today an extension ... disease.  Galapagos will fund and complete a Phase 2 ... rapid progression into Phase 3.  Upon successful completion of ... Galapagos $50 million.  The terms of the collaboration extension ...
(Date:5/16/2013)... , May 16, 2013  HeartWare International, Inc. (NASDAQ: ... of less invasive, miniaturized circulatory support technologies that are revolutionizing ... Doug Godshall is scheduled to present ... EDT on Monday, May 20, 2013.  The conference is being ... A live webcast of the Company,s presentation at ...
(Date:5/16/2013)... , May 16, 2013 ... in the U.S. to access the widely-used OrthoView digital ... PC and Internet connection to get started. ... software for over 10 years, is dedicated to enabling ... with digital x-ray images, when printed film is unavailable. ...
Breaking Medicine Technology:AbbVie and Galapagos Extend GLPG0634 Collaboration to Include Crohn's Disease 2AbbVie and Galapagos Extend GLPG0634 Collaboration to Include Crohn's Disease 3AbbVie and Galapagos Extend GLPG0634 Collaboration to Include Crohn's Disease 4AbbVie and Galapagos Extend GLPG0634 Collaboration to Include Crohn's Disease 5AbbVie and Galapagos Extend GLPG0634 Collaboration to Include Crohn's Disease 6HeartWare Presentation At The 2013 UBS Global Healthcare Conference To Be Webcast 2OrthoView Announces the U.S. Launch of a New, Subscription-based, Digital Planning and Templating Solution for Individual Orthopaedic Surgeons 2
... Intra-Cellular Therapies, Inc. (ITI),today announced it has initiated ... using its drug candidate ITI-722. ITI-722 acts predominantly,as ... important new,approach to the treatment of SMI. Because ... modulatory activities, ITI believes, ITI-722 can be,used not ...
... Research Is a Winning Pursuit, WASHINGTON, Dec. ... L. Trull President, Foundation for Biomedical,Research:, Biomedical ... of pursuit" in 1980 earned Mario Capecchi a ... setback, the Harvard-educated genetics professor,persisted toward his goal. ...
Cached Medicine Technology:Intra-Cellular Therapies Initiates Phase 2 Clinical Trial for Sleep Maintenance Insomnia 2Intra-Cellular Therapies Initiates Phase 2 Clinical Trial for Sleep Maintenance Insomnia 3Intra-Cellular Therapies Initiates Phase 2 Clinical Trial for Sleep Maintenance Insomnia 4Nobel Prize-Winning Discovery 2Nobel Prize-Winning Discovery 3
(Date:5/19/2013)... May 19, 2013 The Pradaxa lawyers ... Conference was recently convened for hundreds of Pradaxa ... now underway in U.S. District Court, Southern District of ... website on May 14th, the Conference addressed the status ... reported during the Conference that Defendants submitted a list ...
(Date:5/19/2013)... The Fat Loss Code program developed by Shawn Stevenson covers ... get in shape, and gain a healthy life regardless of ... a natural fat loss system that provides people with effective ... loss diet program claimed that The Fat Loss Code is ... fat off long-term. After Shawn Stevenson launched this new body ...
(Date:5/19/2013)... 2013 Exciting new Skin Brushes are ... a great practice known through the ages but is ... dry body brushing, has so many benefits for our ... Beauty®. "We love that circulation and lymphatic systems get ... the skin, is supported through Skin Brushing." , Why ...
(Date:5/19/2013)... Atlanta, GA (PRWEB) May 19, 2013 The ... and 2pm at the Columbus Georgia Convention & Trade Center ... are invited to attend. AMTC auditions are free of charge. ... the starting point for hundreds of successful artists and grads ... new face for European Tombolini , Chris Young - on ...
(Date:5/19/2013)... (PRWEB) May 19, 2013 The Da ... to follow developments in the nation’s first trial involving ... underway in Washington State Superior Court, was filed by ... after he suffered complications in a robot-assisted prostate removal, ... Da Vinci robotic surgery lawsuit alleges those ...
Breaking Medicine News(10 mins):Health News:Pradaxa Lawyers at Bernstein Liebhard LLP Report on Recent Status Conference in Federal Pradaxa Litigation 2Health News:Pradaxa Lawyers at Bernstein Liebhard LLP Report on Recent Status Conference in Federal Pradaxa Litigation 3Health News:Weight Loss Secrets | How “The Fat Loss Code” Helps People Gain A Healthy Life And Get In Shape - Health Review 2Health News:Exciting New Skin Brushes at Sublime Beauty® Bring Health and Beauty Benefits; Celebrities and Models Know the Secret 2Health News:Actors, Models and Talent for Christ Hosting Auditions in Columbus, GA June 1st in Search of Local Talent 2Health News:Da Vinci Surgical Robot Lawyers at Wright & Schulte LLC Note Recent Developments in Da Vinci Robot Lawsuit Trial 2Health News:Da Vinci Surgical Robot Lawyers at Wright & Schulte LLC Note Recent Developments in Da Vinci Robot Lawsuit Trial 3Health News:Da Vinci Surgical Robot Lawyers at Wright & Schulte LLC Note Recent Developments in Da Vinci Robot Lawsuit Trial 4
... researchers looked at the distribution of primary stroke ... national organizations (such as The Joint Commission in ... They found that 24 percent of acute general ... the eight states that have a state-based program ...
... in the brains of patients with Alzheimer disease collude, resulting ... cells, according to new findings published online in Neurobiology ... pathological forms of two proteins, amyloid beta and tau, which ... patients plaques and tangles may work in tandem ...
... Researchers from Boston Medical Center (BMC) and Boston ... use as a risk factor for not receiving all ... in BMJ Open, identify unhealthy substance use ... influenza vaccination. Cancer and influenza ...
... influences decision making on issues whose consequences will only ... the annual Addiction Science Awards at this year,s Intel ... largest science competition for high school students. The Intel ... ceremony Thursday night in Los Angeles. The awards were ...
... Elsevier, the world,s leading publisher of scientific ... India,s first contract research organization, has signed a ... Reaxys for all Syngene researchers. Reaxys will help ... the ever-expanding and highly competitive Indian pharmaceutical, chemical ...
... This release is also available in Chinese on ... the discomfort and pain some people experience while using in-ear ... canal from external sound -- have found not only what ... In two separate papers and a presentation at the 130th ...
Cached Medicine News:Health News:2 defective proteins conspire to impair the nerve cell's 'powerhouse' in Alzheimer's disease 2Health News:2 defective proteins conspire to impair the nerve cell's 'powerhouse' in Alzheimer's disease 3Health News:Study finds unhealthy substance use a risk factor for not receiving some preventive health services 2Health News:Altruistic decision making focus of NIDA's Addiction Science Award 2Health News:Altruistic decision making focus of NIDA's Addiction Science Award 3Health News:Sound safety 2Health News:Sound safety 3Health News:Sound safety 4Health News:Sound safety 5
... This is the only ... counts in patient synovial fluid ... hemocytometer. It is also an ... which may indicate a pathological ...
... is intended as a means ... assay methods used for the ... urine samples. This control is ... This control is supplied as ...
... validates urine dipstick readings by applying the ... plastic dropper tip designed for easy dispensing ... the addition of creatinine and microalbumin. Assay ... results for hCG for early pregnancy detection ...
... Pyrogallol Red Molybdate dye binding ... method for total protein quantitation with ... urine or cerebrospinal fluid (CSF) in ... includes four reagent standards (level 2, ...
Medicine Products: